Richard P Gallagher

Author PubWeight™ 71.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006 4.13
2 Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol 2010 2.44
3 Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009 2.32
4 GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer 2010 2.18
5 Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005 2.10
6 From consent to institutions: designing adaptive governance for genomic biobanks. Soc Sci Med 2011 1.93
7 Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006 1.80
8 A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 2006 1.80
9 Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 2007 1.78
10 Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev 2004 1.70
11 Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: the Cross-Canada Childhood Leukemia Study. Am J Epidemiol 2007 1.65
12 The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 2006 1.51
13 Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007 1.44
14 Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. J Clin Oncol 2013 1.36
15 Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 2005 1.32
16 Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol Biomarkers Prev 2004 1.31
17 Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005 1.17
18 Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 2003 1.15
19 CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007 1.14
20 The Canadian Partnership for Tomorrow Project: building a pan-Canadian research platform for disease prevention. CMAJ 2010 1.10
21 Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer 2011 1.04
22 Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004 1.03
23 Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007 1.01
24 Identification of occupational cancer risks in British Columbia: a population-based case-control study of 1129 cases of bladder cancer. J Occup Environ Med 2005 1.01
25 Sun-related behavior after a diagnosis of cutaneous malignant melanoma. Melanoma Res 2007 0.98
26 Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma. BMC Med Genet 2009 0.97
27 Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health 2003 0.97
28 Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiol Biomarkers Prev 2010 0.95
29 Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 2008 0.95
30 Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. JAMA Oncol 2015 0.95
31 Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. JAMA Dermatol 2013 0.94
32 Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial. J Am Acad Dermatol 2005 0.93
33 Carbohydrates and colorectal cancer risk among Chinese in North America. Cancer Epidemiol Biomarkers Prev 2002 0.93
34 Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2009 0.92
35 Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. JAMA Dermatol 2014 0.91
36 Prostate cancer risk and exposure to pesticides in British Columbia farmers. Prostate 2010 0.91
37 Cancer risk in aluminum reduction plant workers (Canada). Cancer Causes Control 2006 0.90
38 MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study. Cancer Causes Control 2010 0.90
39 Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma. Int J Cancer 2005 0.88
40 Exposure to anesthetic gases and congenital anomalies in offspring of female registered nurses. Am J Ind Med 2011 0.88
41 Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study. Melanoma Res 2009 0.88
42 Genetic variation in cell death genes and risk of non-Hodgkin lymphoma. PLoS One 2012 0.87
43 Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomarkers Prev 2008 0.87
44 A systematic evaluation of the ataxia telangiectasia mutated gene does not show an association with non-Hodgkin lymphoma. Int J Cancer 2007 0.86
45 Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002 0.85
46 Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs. BMC Nurs 2010 0.84
47 Prediagnostic C-peptide and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2007 0.84
48 Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer 2008 0.83
49 Twenty-four-hour light exposure and melatonin levels among shift workers. J Occup Environ Med 2005 0.83
50 Mortality and cancer incidence in a cohort of registered nurses from British Columbia, Canada. Am J Ind Med 2007 0.83
51 Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population. J Invest Dermatol 2011 0.82
52 Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J Cancer 2014 0.81
53 Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Causes Control 2014 0.81
54 Predicting the performance of a genetic testing service for cancer susceptibility. Genet Test 2007 0.78
55 Identifying related cancer types based on their incidence among people with multiple cancers. Emerg Themes Epidemiol 2006 0.78
56 MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell Melanoma Res 2014 0.77
57 Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950-94. Occup Med (Lond) 2007 0.77
58 Occupational exposure and ovarian cancer risk. Cancer Causes Control 2014 0.77
59 Rates of congenital anomalies and other adverse birth outcomes in an offspring cohort of registered nurses from British Columbia, Canada. Can J Public Health 2010 0.76
60 Reducing sunbed use in young people. BMJ 2010 0.75
61 Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One 2013 0.75
62 Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma. PLoS One 2013 0.75
63 Congenital anomalies in the offspring of nurses: association with area of employment during pregnancy. Int J Occup Environ Health 2011 0.75
64 Do work-related breast cancer risks in pre-menopausal women depend on family history? Chronic Dis Can 2005 0.75
65 Keynote comment: sun exposure--cause or prevention? Lancet Oncol 2005 0.75
66 Implications of the age range in a population-based BRCA1 testing program with eligibility based on family history of breast and ovarian cancer. Genet Test 2004 0.75